Delivery Order SPE2DB20D3104-SPE2DB22FV8J7

Award Date 7/26/22
Potential Completion Date 7/27/22
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,109.32, is for the delivery of Imiquimod 5% Cream Packets and has an ultimate completion date of May 21, 2024. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the purchase of IMIQUIMOD 5% CREAM PACKET 24S, a pharmaceutical product, with a ceiling value of $1,127.36 and a period of performance through October 18, 2023. The contract is a firm fixed price, delivery order contract, and there was no set-aside used....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Imiquimod 3.75% cream in 28-count packages, with a ceiling value of $17,482.59 and a period of performance through April 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain network to fulfill government contracts, particularly for the Department...
This federal contract award, valued at $6,103.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMIQUIMOD 5% CREAM PACKET 24S, a medical product, with a completion date of June 22, 2023. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Imiquimod 3.75% Cream Pump, 7.5 gm. The $3,193.43 firm fixed-price contract has an ultimate completion date of April 18, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA)...
This federal contract award, with an ID of SPE2DX15D7062|SPE2DX25FJCZT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,020.00 firm fixed-price delivery order is for the supply of IMIQUIMOD 5% CREAM 24S, a medical product, with a completion date of January 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $12,951.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the delivery of Imiquimod 5% Cream in 24-count packages. The contract is a Firm Fixed Price Delivery Order that runs through January 22, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,599.80 Firm Fixed Price Delivery Order is for the provision of Imiquimod 3.75% Cream Pump 7.5GM, a pharmaceutical product. The contract has an ultimate completion date of January 16, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a...
The Defense Logistics Agency awarded a $199 firm fixed price delivery order to Amerisourcebergen Drug Corporation for IMIQUIMOD 5% CREAM PACKETS (24 packets per unit). Performance will occur in Conshohocken, Pennsylvania by October 19, 2023. No set-aside provisions were applied to this order placed under an existing DLA-wide contract vehicle. The agency supports military readiness by procuring and providing medical supplies and pharmaceuticals to armed forces worldwide. This small order for a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,925.08 firm fixed-price contract is for the supply of Pimecrolimus 1% cream, a prescription topical medication. The award has an ultimate completion date of September 4, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, to provide a broad range of...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB22FV8J7
    Delivery Order

This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on July 26, 2022. The $1,530.58 firm fixed-price contract is for the delivery of Imiquimod 5% cream packets. The contract has an ultimate completion date of July 27, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 10:29 AM